These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 36047117

  • 1. Copper Deficiency in Wilson's Disease with a Normal Zinc Value.
    Ueda M, Katsuse K, Kakumoto T, Kobayashi S, Ishiura H, Mitsui J, Toda T.
    Intern Med; 2023 Apr 01; 62(7):1073-1076. PubMed ID: 36047117
    [Abstract] [Full Text] [Related]

  • 2. Can Patients with Wilson's Disease Develop Copper Deficiency?
    Chevalier K, Obadia MA, Djebrani-Oussedik N, Poujois A.
    Mov Disord Clin Pract; 2023 Sep 01; 10(9):1306-1316. PubMed ID: 37772303
    [Abstract] [Full Text] [Related]

  • 3. Anemia following zinc treatment for Wilson's disease: a case report and literature review.
    Cai S, Gong JY, Yang J, Wang JS.
    BMC Gastroenterol; 2019 Jul 09; 19(1):120. PubMed ID: 31288754
    [Abstract] [Full Text] [Related]

  • 4. Axonal sensory motor neuropathy in copper-deficient Wilson's disease.
    Foubert-Samier A, Kazadi A, Rouanet M, Vital A, Lagueny A, Tison F, Meissner W.
    Muscle Nerve; 2009 Aug 09; 40(2):294-6. PubMed ID: 19609919
    [Abstract] [Full Text] [Related]

  • 5. Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate.
    Dzieżyc K, Litwin T, Sobańska A, Członkowska A.
    Neurol Neurochir Pol; 2014 Aug 09; 48(3):214-8. PubMed ID: 24981187
    [Abstract] [Full Text] [Related]

  • 6. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
    Lozano Herrero J, Muñoz Bertrán E, Ortega González I, Gómez Espín R, López Espín MI.
    Gastroenterol Hepatol; 2012 Dec 09; 35(10):704-7. PubMed ID: 22609346
    [Abstract] [Full Text] [Related]

  • 7. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F.
    Encephale; 2007 Dec 09; 33(6):924-32. PubMed ID: 18789784
    [Abstract] [Full Text] [Related]

  • 8. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ.
    Drugs; 1995 Aug 09; 50(2):240-9. PubMed ID: 8521757
    [Abstract] [Full Text] [Related]

  • 9. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P, Choksi M, Goel A, Zachariah U, Sajith KG, Ramachandran J, Chandy G, Kurian G, Rebekah G, Eapen CE.
    Indian J Gastroenterol; 2018 Jan 09; 37(1):31-38. PubMed ID: 29457214
    [Abstract] [Full Text] [Related]

  • 10. Use of zinc-copper metabolic interactions in the treatment of Wilson's disease.
    Brewer GJ, Yuzbasiyan-Gurkan V, Lee DY.
    J Am Coll Nutr; 1990 Oct 09; 9(5):487-91. PubMed ID: 2258535
    [Abstract] [Full Text] [Related]

  • 11. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU.
    Brain Dev; 2006 Apr 09; 28(3):141-6. PubMed ID: 16466879
    [Abstract] [Full Text] [Related]

  • 12. [Application of zinc agents in Wilson's disease].
    Liang C, Hou W, Duan ZP, Zheng SJ.
    Zhonghua Gan Zang Bing Za Zhi; 2024 Sep 20; 32(9):850-853. PubMed ID: 39375107
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Wilson's disease with zinc: XV long-term follow-up studies.
    Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK.
    J Lab Clin Med; 1998 Oct 20; 132(4):264-78. PubMed ID: 9794697
    [Abstract] [Full Text] [Related]

  • 14. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study.
    Marcellini M, Di Ciommo V, Callea F, Devito R, Comparcola D, Sartorelli MR, Carelli G, Nobili V.
    J Lab Clin Med; 2005 Mar 20; 145(3):139-43. PubMed ID: 15871305
    [Abstract] [Full Text] [Related]

  • 15. Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson's disease at diagnosis.
    Diao SP, Zhuang YS, Huang YQ, Zhou ZH, Liu AQ, Hong MF.
    BMC Neurol; 2023 Feb 28; 23(1):89. PubMed ID: 36855079
    [Abstract] [Full Text] [Related]

  • 16. [The role of zinc in the initial treatment of Wilson's disease in children].
    Cacić M, Percl M, Jadresin O, Kolacek S.
    Lijec Vjesn; 2000 Mar 28; 122(3-4):77-81. PubMed ID: 10932534
    [Abstract] [Full Text] [Related]

  • 17. Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury.
    Coni P, Pichiri G, Lachowicz JI, Ravarino A, Ledda F, Fanni D, Gerosa C, Piras M, Coghe F, Gibo Y, Cau F, Castagnola M, Van Eyken P, Saba L, Piludu M, Faa G.
    Molecules; 2021 Oct 31; 26(21):. PubMed ID: 34771023
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens.
    Hill GM, Brewer GJ, Prasad AS, Hydrick CR, Hartmann DE.
    Hepatology; 1987 Oct 31; 7(3):522-8. PubMed ID: 3570163
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance.
    Hill GM, Brewer GJ, Juni JE, Prasad AS, Dick RD.
    Am J Med Sci; 1986 Dec 31; 292(6):344-9. PubMed ID: 3799705
    [Abstract] [Full Text] [Related]

  • 20. The treatment of Wilson's disease with zinc. IV. Efficacy monitoring using urine and plasma copper.
    Brewer GJ, Hill G, Prasad A, Dick R.
    Proc Soc Exp Biol Med; 1987 Apr 31; 184(4):446-55. PubMed ID: 3562454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.